CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
National Longitudinal Cohort of Hematological Diseases
- Status
- RECRUITING
- Phase
- N/A
Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
Observational Study of Home Administration of Carfilzomib
- Status
- WITHDRAWN
- Phase
- N/A
BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
FT538 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)
- Status
- UNKNOWN
- Phase
- N/A
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation
- Status
- COMPLETED
- Phase
- NA
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Immunomaintenance Using POmalidomide With Elotuzumab afteR Second Autologous Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1